{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:25:40Z","timestamp":1791260740442,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T00:00:00Z","timestamp":1476144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T00:00:00Z","timestamp":1476144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In this article, we report the safety evaluation of gadolinium-based nanoparticles in nonhuman primates (NHP) in the context of magnetic resonance imaging (MRI) studies in atherosclerosis bearing animals and healthy controls. In healthy NHP, the pharmacokinetics and toxicity profiles demonstrated the absence of dose, time, and sex-effects, as well as a suitable tolerance of intravenous administration of the nanoparticles. We investigated their imaging properties for arterial plaque imaging in a standard diet or a high cholesterol diet NHP, and compared their characteristics with clinically applied Gd-chelate. This preliminary investigation reports the efficient and safe imaging of atherosclerotic plaques.<\/jats:p>","DOI":"10.1038\/srep35053","type":"journal-article","created":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T10:01:36Z","timestamp":1476180096000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Safety Evaluation and Imaging Properties of Gadolinium-Based Nanoparticles in nonhuman primates"],"prefix":"10.1038","volume":"6","author":[{"given":"Shady","family":"Kotb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao","family":"Piraquive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Lamberton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Lux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Verset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Di Cataldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Contamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Tillement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Canet-Soulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Sancey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,11]]},"reference":[{"key":"BFsrep35053_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrcardio.2015.164","volume":"13","author":"K Yahagi","year":"2016","unstructured":"Yahagi, K. et al. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. Nat Rev Cardiol 13, 79\u201398, doi: 10.1038\/nrcardio.2015.164 (2016).","journal-title":"Nat Rev Cardiol"},{"key":"BFsrep35053_CR2","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1056\/NEJMra1216063","volume":"368","author":"P Libby","year":"2013","unstructured":"Libby, P. Mechanisms of acute coronary syndromes and their implications for therapy. The New England journal of medicine 368, 2004\u20132013, doi: 10.1056\/NEJMra1216063 (2013).","journal-title":"The New England journal of medicine"},{"key":"BFsrep35053_CR3","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3978\/j.issn.2223-3652.2015.03.01","volume":"5","author":"PD Adamson","year":"2015","unstructured":"Adamson, P. D., Vesey, A. T., Joshi, N. V., Newby, D. E. & Dweck, M. R. Salt in the wound: (18)F-fluoride positron emission tomography for identification of vulnerable coronary plaques. Cardiovasc Diagn Ther 5, 150\u2013155, doi: 10.3978\/j.issn.2223-3652.2015.03.01 (2015).","journal-title":"Cardiovasc Diagn Ther"},{"key":"BFsrep35053_CR4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jcmg.2015.12.003","volume":"9","author":"MR Dweck","year":"2016","unstructured":"Dweck, M. R., Puntman, V., Vesey, A. T., Fayad, Z. A. & Nagel, E. M. R. Imaging of Coronary Arteries and Plaques. JACC Cardiovasc Imaging 9, 306\u2013316, doi: 10.1016\/j.jcmg.2015.12.003 (2016).","journal-title":"JACC Cardiovasc Imaging"},{"key":"BFsrep35053_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10334-007-0078-y","volume":"20","author":"E Canet-Soulas","year":"2007","unstructured":"Canet-Soulas, E. & Letourneur, D. Biomarkers of atherosclerosis and the potential of MRI for the diagnosis of vulnerable plaque. Magma 20, 129\u2013142, doi: 10.1007\/s10334-007-0078-y (2007).","journal-title":"Magma"},{"key":"BFsrep35053_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1586\/14779072.5.1.69","volume":"5","author":"CM Kramer","year":"2007","unstructured":"Kramer, C. M. & Anderson, J. D. MRI of atherosclerosis: diagnosis and monitoring therapy. Expert Rev Cardiovasc Ther 5, 69\u201380, doi: 10.1586\/14779072.5.1.69 (2007).","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"BFsrep35053_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0140-6736(05)76159-6","volume":"353","author":"AR Moody","year":"1999","unstructured":"Moody, A. R., Allder, S., Lennox, G., Gladman, J. & Fentem, P. Direct magnetic resonance imaging of carotid artery thrombus in acute stroke. Lancet 353, 122\u2013123 (1999).","journal-title":"Lancet"},{"key":"BFsrep35053_CR8","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1161\/01.CIR.0000074204.92443.37","volume":"107","author":"RE Murphy","year":"2003","unstructured":"Murphy, R. E. et al. Prevalence of complicated carotid atheroma as detected by magnetic resonance direct thrombus imaging in patients with suspected carotid artery stenosis and previous acute cerebral ischemia. Circulation 107, 3053\u20133058, doi: 10.1161\/01.CIR.0000074204.92443.37 (2003).","journal-title":"Circulation"},{"key":"BFsrep35053_CR9","doi-asserted-by":"crossref","unstructured":"Dweck, M. R. et al. Imaging of coronary atherosclerosis - evolution towards new treatment strategies. Nat Rev Cardiol, doi: 10.1038\/nrcardio.2016.79 (2016).","DOI":"10.1038\/nrcardio.2016.79"},{"key":"BFsrep35053_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11883-016-0583-4","volume":"18","author":"RH van Hoof","year":"2016","unstructured":"van Hoof, R. H., Heeneman, S., Wildberger, J. E. & Kooi, M. E. Dynamic Contrast-Enhanced MRI to Study Atherosclerotic Plaque Microvasculature. Curr Atheroscler Rep 18, 33, doi: 10.1007\/s11883-016-0583-4 (2016).","journal-title":"Curr Atheroscler Rep"},{"key":"BFsrep35053_CR11","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1055\/s-0035-1553500","volume":"187","author":"P Fries","year":"2015","unstructured":"Fries, P. et al. Evaluation of a Gadolinium-Based Nanoparticle (AGuIX) for Contrast-Enhanced MRI of the Liver in a Rat Model of Hepatic Colorectal Cancer Metastases at 9.4 Tesla. RoFo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 187, 1108\u20131115, doi: 10.1055\/s-0035-1553500 (2015).","journal-title":"RoFo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin"},{"key":"BFsrep35053_CR12","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.2217\/nnm.15.30","volume":"10","author":"F Lux","year":"2015","unstructured":"Lux, F. et al. Gadolinium-based nanoparticles for theranostic MRI-radiosensitization. Nanomedicine 10, 1801\u20131815, doi: 10.2217\/nnm.15.30 (2015).","journal-title":"Nanomedicine"},{"key":"BFsrep35053_CR13","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1021\/nn506750r","volume":"9","author":"ME Lobatto","year":"2015","unstructured":"Lobatto, M. E. et al. Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging. ACS nano 9, 1837\u20131847, doi: 10.1021\/nn506750r (2015).","journal-title":"ACS nano"},{"key":"BFsrep35053_CR14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1161\/CIRCRESAHA.111.300576","volume":"112","author":"MD Majmudar","year":"2013","unstructured":"Majmudar, M. D. et al. Polymeric nanoparticle PET\/MR imaging allows macrophage detection in atherosclerotic plaques. Circ Res 112, 755\u2013761, doi: 10.1161\/CIRCRESAHA.111.300576 (2013).","journal-title":"Circ Res"},{"key":"BFsrep35053_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jconrel.2015.09.027","volume":"217","author":"V Bagalkot","year":"2015","unstructured":"Bagalkot, V. et al. Hybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals. J Control Release 217, 243\u2013255, doi: 10.1016\/j.jconrel.2015.09.027 (2015).","journal-title":"J Control Release"},{"key":"BFsrep35053_CR16","doi-asserted-by":"publisher","first-page":"12299","DOI":"10.1002\/anie.201104104","volume":"50","author":"F Lux","year":"2011","unstructured":"Lux, F. et al. Ultrasmall rigid particles as multimodal probes for medical applications. Angew Chem Int Ed Engl 50, 12299\u201312303, doi: 10.1002\/anie.201104104 (2011).","journal-title":"Angew Chem Int Ed Engl"},{"key":"BFsrep35053_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jconrel.2016.07.021","volume":"238","author":"A Detappe","year":"2016","unstructured":"Detappe, A. et al. Advanced multimodal nanoparticles delay tumor progression with clinical radiation therapy. J Control Release 238, 103\u2013113, doi: 10.1016\/j.jconrel.2016.07.021 (2016).","journal-title":"J Control Release"},{"key":"BFsrep35053_CR18","doi-asserted-by":"crossref","unstructured":"Verry, C. et al. MRI-guided clinical 6-MV radiosensitization of glioma using a unique gadolinium-based nanoparticles injection. Nanomedicine, doi: 10.2217\/nnm-2016-0203 (2016).","DOI":"10.2217\/nnm-2016-0203"},{"key":"BFsrep35053_CR19","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1021\/acsnano.5b00552","volume":"9","author":"L Sancey","year":"2015","unstructured":"Sancey, L. et al. Long-term in vivo clearance of gadolinium-based AGuIX nanoparticles and their biocompatibility after systemic injection. ACS nano 9, 2477\u20132488, doi: 10.1021\/acsnano.5b00552 (2015).","journal-title":"ACS nano"},{"key":"BFsrep35053_CR20","doi-asserted-by":"publisher","first-page":"6122","DOI":"10.1002\/chem.201203003","volume":"19","author":"A Mignot","year":"2013","unstructured":"Mignot, A. et al. A top-down synthesis route to ultrasmall multifunctional Gd-based silica nanoparticles for theranostic applications. Chemistry 19, 6122\u20136136, doi: 10.1002\/chem.201203003 (2013).","journal-title":"Chemistry"},{"key":"BFsrep35053_CR21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1161\/CIRCIMAGING.108.826826","volume":"2","author":"JA Ronald","year":"2009","unstructured":"Ronald, J. A. et al. Comparison of gadofluorine-M and Gd-DTPA for noninvasive staging of atherosclerotic plaque stability using MRI. Circ Cardiovasc Imaging 2, 226\u2013234, doi: 10.1161\/CIRCIMAGING.108.826826 (2009).","journal-title":"Circ Cardiovasc Imaging"},{"key":"BFsrep35053_CR22","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1096\/fj.14-269043","volume":"29","author":"OL Blanchard","year":"2015","unstructured":"Blanchard, O. L. & Smoliga, J. M. Translating dosages from animal models to human clinical trials--revisiting body surface area scaling. FASEB J 29, 1629\u20131634, doi: 10.1096\/fj.14-269043 (2015).","journal-title":"FASEB J"},{"key":"BFsrep35053_CR23","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw, S., Nihal, M. & Ahmad, N. Dose translation from animal to human studies revisited. FASEB J 22, 659\u2013661, doi: 10.1096\/fj.07-9574LSF (2008).","journal-title":"FASEB J"},{"key":"BFsrep35053_CR24","doi-asserted-by":"crossref","unstructured":"Celeng, C., Takx, R. A., Ferencik, M. & Maurovich-Horvat, P. Non-invasive and invasive imaging of vulnerable coronary plaque. Trends Cardiovasc Med, doi: 10.1016\/j.tcm.2016.03.005 (2016).","DOI":"10.1016\/j.tcm.2016.03.005"},{"key":"BFsrep35053_CR25","doi-asserted-by":"publisher","first-page":"E161","DOI":"10.1016\/j.atherosclerosis.2015.04.841","volume":"241","author":"V Di Cataldo","year":"2015","unstructured":"Di Cataldo, V. et al. Mr and pet\/ct imaging use to stratify cardiovascular risks in non-human primates under atherogenic diet. Atherosclerosis 241, E161\u2013E161 (2015).","journal-title":"Atherosclerosis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep35053.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep35053","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep35053.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T01:20:31Z","timestamp":1672881631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep35053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,11]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,16]]}},"alternative-id":["BFsrep35053"],"URL":"https:\/\/doi.org\/10.1038\/srep35053","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,11]]},"assertion":[{"value":"15 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.L. and T.O. have to disclose the patent WO2011\/135101. The patent protects the nanoparticles described in this publication: AGuIX<sup>\u00ae<\/sup>.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35053"}}